Winterlight Labs

HEAR-MHE study: Automated speech analysis identifies minimal hepatic encephalopathy and may predict future overt hepatic encephalopathy
Bloom P.P., Fisher C.J., Tedesco N., Kamdar N., Garrido-Trevino L., Robin J., Asrani S.K., Lok A.S. (2024)
Hepatology. Read more

Analytical validation of a novel quality assurance approach for COAs in Alzheimer’s Disease clinical trials
Newsome, R.N., Kindellan R., Fidalgo C., Simpson W. (2024)
ISCTM 2024 Autumn Conference. Read more

Digital remote assessment of speech acoustics in cognitively unimpaired adults: feasibility, reliability and associations with amyloid pathology
van den Berg R., de Boer C., Zwan M.D., Jutten R.J., van Liere M., van de Glind M-C.A.B.J., Dubbelman M.A., Schlüter L.M., van Harten A.C., Teunissen C.E., van de Giessen E., Barkhof F., Collij L.E., Robin J., Simpson W., Harrison J.E., van der Flier W.M., Sikkes S.A.M. (2024)
Alzheimer's Research & Therapy.Read more

Speech characteristics and their association with neuroimaging and CSF biomarkers of AD pathology
Simpson W., Spilka M., Xu M., Robin J. (2024)
Alzheimer's Association International Conference (AAIC). Read more

Robustness and generalizability of a speech- based digital biomarker derived from recordings of the Clinical Dementia Rating (CDR) interview
Spilka M., Xu M., Toth B., Hashemifar S., Amora R., Robin J., Teng E., Monteiro C., Simpson W. (2024)
Alzheimer's Association International Conference (AAIC). Read more

Automated, Objective Speech and Language Markers of Longitudinal Changes in Psychosis Symptoms
Tang S.X., Spilka M.J., John M., Birnbaum M.L., Saito E., Berretta S.A., Behbehani L.M., Liberman M.Y., Malhotra A.K., Kane J.M., Simpson W. (2024)
medRxiv. Read more

Computational speech markers of negative symptoms show evidence of being robust to antipsychotic dose and extrapyramidal symptoms in schizophrenia
Spilka M.J., Robin J., Nikzad A.H., Behbehani L., Berretta S., Xu M., Kane J.M., Simpson W., Tang S.X. (2024)
PsyArXiv. Read more

Assessing and Monitoring Clinical Severity in Depressive Disorders Using Automated Speech Analysis
Spilka M.J., Xu M., Tang S.X., Behbehani L., Robin J., Simpson W. (2024)
American Society of Clinical Psychopharmacology (ASCP) 2024 Annual Meeting. Read more

Zero-Shot Multi-Lingual Speaker Verification in Clinical Trials
Akram A., Stanojevic M., Ehghaghi M., Novikova J. (2024)
arXiv. Read more

Computational speech & language features for within- & between-subject symptom characterization in first-episode psychosis
Spilka M., Yeung A., Xu M., Jebanesan B., Khan W., Ahmed S., Simpson W., Robin J., Naeem F. (2024)
Schizophrenia International Research Society 2024 Annual Congress. Read more

Linguistic changes in neurodegenerative diseases relate to clinical symptoms
Gumus M., Koo M., Studzinski C.M., Bhan A., Robin J., Black S.E. (2024)
Frontiers in Neurology. Read more

Leveraging speech production as a physiological marker of cognitive decline: Demonstration of the role of timing and acoustic changes
Sorinas J., Huynh M.T.D., Hannesdottir K., Robin J., Simpson W., Coello N., Caputo A., Riviere M.-E., Curcic J. (2024)
International Conference on Alzheimer’s and Parkinson’s Diseases and related neurological disorders (AD/PD 2024). Read more

Towards fully automated rating scale review: Identifying speech feature signature for administration variances in CDR interview during Alzheimer’s Disease clinical trials
Newsome R.N., Kindellan R., Fidalgo C., Simpson W. (2024)
International Society for CNS Clinical Trials and Methodology (ISCTM) 20th Annual Meeting. Read more

Cognitive components of aging-related increase in word-finding difficulty
Wei H.T., Kulzhabayeva D., Erceg L., Robin J., Hu Y.Z., Chignell M., Meltzer J.A. (2024)
Aging, Neuropsychology, and Cognition. Read more

Detecting bulbar amyotrophic lateral sclerosis (ALS) using automatic acoustic analysis
Simmatis L.E.R., Robin J., Spilka M.J., Yunusova Y. (2024)
BioMedical Engineering OnLine. Read more

Validation of automated pipeline for the assessment of a motor speech disorder in amyotrophic lateral sclerosis (ALS)
Simmatis L., Robin J., Pommée T., McKinlay S., Sran R., Taati N., Truong J., Koyani B., Yunusova Y. (2023)
Digital Health. Read more

Generalizability and Robustness of Large Language Models Detecting Alzheimer’s Disease from Speech.
Novikova J. (2023)
GenBench at EMNLP (Empirical Methods in Natural Language Processing) International Conference. Read more

How Much Speech Data Is Needed for Tracking Language Change in Alzheimer’s Disease? A Comparison of Random Length, 5-Min, and 1-Min Spontaneous Speech Samples.
Petti U., Baker S., Korhonen A., Robin J. (2023)
Digital Biomarkers. Read more

Robustness and generalizability of a speech based composite score for measuring disease progression in AD.
Spilka M., Xu M., Robin J., Simpson W. (2023)
Clinical Trials on Alzheimer’s Disease (CTAD) Conference. Read more

Development of a speech-based composite score for remotely quantifying language changes in frontotemporal dementia
Robin J., Xu M., Kaufman L., Simpson W., McCaughey S., Tatton N., Wolfus C., Ward M. (2023)
Cognitive and Behavioral Neurology. Read more

Longitudinal tracking of speech changes in ALS using a novel remote assessment.
Simmatis L., Robin J., Spilka M., Yunusova Y. (2023)
22nd Annual Meeting of the Northeast ALS Consortium. Read more

PROSA—a multicenter prospective observational study to develop low-burden digital speech biomarkers in ALS and FTD.
Tröger J., Baltes J., Baykara E., Kasper E., Kring M., Linz N., Robin J., Schäfer S., Schneider A., Hermann A. (2023)
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. Read more

Speech Changes in Neurodegenerative Diseases Relate to Clinical Outcomes
Gumus M., Koo M., Bhan A., Robin J., Black S.E. (2023)
Alzheimer's Association International Conference. Read more

Natural Speech as a Digital Biomarker in Preclinical Alzheimer’s Disease: Usability of a Remote Burst Speech Assessment.
van den Berg R.L., Alzheimer Center Amsterdam (2023)
Alzheimer's Association International Conference. Read more

Automated detection of progressive speech changes in early Alzheimer's disease.
Robin J., Xu M., Balagopalan A., Novikova J., Kahn L., Oday A., Hejrati M., Hashemifar S., Negahdar M., Simpson W., Teng E. (2023)
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring. Read more

Evaluating the utility of daily speech assessments for monitoring depression symptoms.
Gumus M., DeSouza D.D., Xu M., Fidalgo C., Simpson W., Robin J. (2023)
Digital Health. Read more

Computational linguistic analysis of speech tasks indexes symptom severity and change in Arabic-speaking individuals with schizophrenia.
Spilka M.J., Xu M., Robin J., Simpson W. (2023)
American Society for Clinical Psychopharmacology (ASCP) Meeting. Read more

Do motor symptoms and antipsychotic medications influence the digital speech assessment of negative symptoms in schizophrenia spectrum disorders?
Spilka M.J., Robin J., Nikzad A., Behbehani L., Beretta S., Xu M., Simpson W., Tang S.X. (2023)
Schizophrenia International Research Society. Read more

Computational speech and language biomarkers for psychosis symptoms during acute hospitalization.
Tang S.X., Spilka M.J., Berretta S., Behbehani L., Birnbaum M., Saito E., Costakis A., Robin J., John M., Liberman M., Simpson B., Kane J.M. (2023)
Schizophrenia International Research Society. Read more

Detecting bulbar amyotrophic lateral sclerosis (ALS) using automatic acoustic analysis.
Simmatis L., Robin J., Yunusova Y. (2023)
International Conference on Aging, Innovation, and Rehabilitation. Read more

Task-specific sensitivity of digital speech assessment to symptom severity in first-episode psychosis.
Spilka M., Yeung A., Xu M., Jebanesan B., Khan W., Ahmed S., Simpson W., Robin J., Naeem F. (2023)
Society of Biological Psychiatry. Read more

Speech biomarkers in mood disorders: a cross-sectional study.
de Azevedo Cardoso T., Rakovski C., Kapczinski F., Simpson W., Robin J. (2023)
Society of Biological Psychiatry. Read more

Speech phenotypes in cognitively healthy participants at risk of developing Alzheimer’s disease.
Sorinas J., Robin J., Simpson W., Curcic J., Hannesdottir K. (2023)
International Conference on Alzheimer's and Parkinson's Diseases (ADPD). Read more

The generalizability of longitudinal changes in speech before Alzheimer’s Disease diagnosis.
Petti U., Baker S., Korhonen A., Robin J. (2023)
Journal of Alzheimer's Disease. Read more

Clinical validation of a novel speech assessment app in amyotrophic lateral sclerosis (ALS).
Simmatis L.E.R., Robin J., Truong J., Pommee T., Koyani B., Yunusova Y. (2023)
International Society for CNS Clinical Trials and Methodology. Read more

Assessments of ADAS-Cog administration quality are comparable across expert and non-expert reviewers.
Kindellan R., Newsome R., Fidalgo C., Robin J. (2023)
International Society for CNS Clinical Trials and Methodology. Read more

Exploring the analytical validity of the Winterlight assessment app – a novel, home-based speech assessment tool – in ALS.
Simmatis L., Robin J., Pommee T., Khoyani B., Yunusova Y. (2022)
33rd International Symposium on ALS/MND. Read more

Validation of an objective, speech-based object content score for measuring disease progression in AD.
Robin J., Xu M., Detke, M., Simpson W. (2022)
Clinical Trials in Alzheimer's Disease. Read more

Accuracy of automated scoring of word recall assessments.
Kindellan, R., Sirotkin, S., Xu, M., Fidalgo, C., Simpson, W., Robin, J. (2022)
Clinical Trials in Alzheimer's Disease. Read more

Cost-effective Models for Detecting Depression from Speech.
Tasnim, M., Novikova, J. (2022)
IEEE International Conference on Machine Learning and Applications (ICMLA). Read more

Slow speech can identify patients with Hepatic Encephalopathy.
Bloom P.P., Robin J., Lok A.S.F. (2022)
American Association for the Study of Liver Diseases: The Liver Meeting. Read more

Multi-modal deep learning system for depression and anxiety detection.
Diep, B., Stanojevic, M., Novikova, J. (2022)
PAI4MH workshop at NeurIPS. Read more

Digital Speech Recording for Quantifying Language Deficit in Brain Tumor Patients: Measuring the Subclinical
Selner A., Robin J., Khan. O.K. (2022)
Congress of Neurological Surgeons. Read more

Analytical validation of automatic speech recognition tools used for voice biomarker development.
Kindellan R., Xu M., Ruan J., Sirotkin S., Robin J. (2022)
International Society for CNS Clinical Trials and Methodology. Read more

Impact of Environmental Noise on Alzheimer’s Disease Detection from Speech: Should You Let a Baby Cry?
Novikova, J. (2022)
COLING Workshop: The 8th Workshop on Noisy User-generated Text (W-NUT). Read more

Data-driven Approach to Differentiating between Depression and Dementia from Noisy Speech and Language Data.
Ehghaghi, M., Rudzicz, F., Novikova, J. (2022)
COLING Workshop: The 8th Workshop on Noisy User-generated Text (W-NUT). Read more

Description of the Method for Evaluating Digital Endpoints in Alzheimer Disease Study: Protocol for an Exploratory, Cross-sectional Study.
Curcic J., Vallejo V., Sorinas J., Sverdlov O., Praestgaard J., Piksa M., Deurinck M., Erdemli G., Bugler M., Tarnanas I., Taptiklis N., Cormack F., Anker R., Masse F., Souillard-Mandar W., Intrator N., Molcho L., Madero E., Bott N., Chambers M., Tamory J., Shulz M., Fernandez G., Simpson W., Robin J., Snaedal JG., Cha J., Hannesdottir K. (2022)
JMIR Research Protocols. Read more

Benchmarking Prognostic Longitudinal Machine Learning Models of Alzheimer’s Disease Using Speech Features.
Ehghaghi, M., Novikova, J., Sett, A., Hejrati, M., Robin, J., Teng, E., Hashemifar, S. (2022)
Applications of Medical AI (AMAI). Read more

Characterizing progressive speech changes in prodromal-to-mild Alzheimer’s disease using natural language processing.
Robin J., Xu M., Balagopalan A., Novikova J., Kahn L., Oday A., Hejrati M., Hashemifar S., Negahdar M., Simpson W., Teng E. (2022)
Alzheimer's Association International Conference. Read more

Acoustic and Linguistic Features of Impromptu Speech and Their Association With Anxiety: Validation Study.
Teferra B.G., Borwein S., DeSouza D.D., Simpson W., Rheault L., Rose J. (2022)
JMIR Mental Health. Read more

Who does what to whom? graph representations of action-predication in speech relate to psychopathological dimensions of psychosis.
Nikzad A.H., Cong Y., Berretta S., Hansel K., Cho S., Pradhan S., Behbehani L., DeSouza D.D., Liberman M.Y., Tang S.X. (2022)
Schizophrenia. Read more

DEPAC: A Corpus for Depression and Anxiety Detection from Speech.
Tasnim, M., Ehghaghi, M., Diep, B., Novikova, J. (2022)
Proceedings of CLPsych. Read more

The burgeoning role of speech and language assessment in schizophrenia spectrum disorders.
DeSouza D.D., Tang S.X., Danilewitz M. (2022)
Psychological Medicine. Read more

Predicting Depression Scores using Digital Speech Measures Collected at High-Frequency
DeSouza D.D., Gumus M., Xu M., Fidalgo C., Simpson W., Robin J. (2022)
Society of Biological Psychiatry (SOBP) Annual Meeting. Read more

Predicting Treatment Outcomes with Computational Speech Features in Hospitalized Patients with Schizophrenia
Tang S.X., DeSouza D.D., Berretta S., John M., Cong Y., Birnbaum M.L., Costakis A., Saito E., Kane J., Simpson B. (2022)
Schizophrenia International Research Society. Read more

Development of a novel digital speech composite measure for Frontotemporal Dementia
Robin J., Xu M., Kaufman L.D., Simpson W., McCaughey S., Wolfus C., Jackson S., Ward M. (2022)
American Academy of Neurology Annual Meeting. Read more

Association Between Speech Characteristics And Cortical [18F]GTP1 Tau PET Tau Levels In Prodromal-To-Mild Alzheimer’s Disease
Robin J., Xu M., Balagopalan A., Novikova J., Hashemifar S., Oday A., Kahn L., Hejrati M., Amora R., Bohorquez S.S., Simpson W., Teng E. (2022)
Alzheimer's & Parkinson's Diseases Conference. Read more

Characterizing Depressive Symptom Fluctuations using Automated Speech Assessment: a Remote Feasibility Study
DeSouza D.D., Gumus M., Fidalgo C., Simpson W., Robin J. (2022)
International Society for CNS Clinical Trials and Methodology. Read more

Using Digital Speech Assessments to Detect Early Signs of Cognitive Impairment.
Robin J., Xu M., Kaufman L.D., Simpson W. (2021)
Frontiers in Digital Health. Read more

Natural Language Processing as an Emerging Tool to Detect Late-Life Depression.
DeSouza D.D., Robin J., Gumus M., Yeung A. (2021)
Frontiers in Psychiatry. Read more

Fluency in spontaneous speech predicts individual variance in executive function among seniors.
Spencer K.A., Robin J., Xu M., Rose M.K., Bialystok E., Meltzer J.A. (2021)
Alzheimer's Association International Conference. Read more

Differential speech and language characteristics across neurodegenerative disorders.
Robin J., Xu M., DeSouza D.D., Gupta A.S., Kaufman L.D., Simpson W. (2021)
Alzheimer's Association International Conference. Read more

Hepatic encephalopathy is associated with slow speech on objective assessment.
Bloom P.P., Robin J., Xu M., Arvind A., Daidone M., Gupta A., Chung R.T. (2021)
The American Journal of Gastroenterology. Read more

Correlating natural language processing and automated speech analysis with clinician assessment to quantify speech-language changes in mild cognitive impairment and Alzheimer’s dementia.
Yeung A., Iaboni A., Rochon E., Lavoie M., Santiago C., Yancheva M., Novikova J., Xu M., Robin J., Kaufman L.D., Mostafa F. (2021)
Alzheimer's Research & Therapy. Read more

Psychometric Approach to Speech Feature Analysis as an Objective Measure of Anxiety.
DeSouza D., Xu M., Fidalgo C., Robin J., Simpson B. (2021)
Society of Biological Psychiatry (SOBP) Annual Meeting. Read more

Comparing Pre-trained and Feature-Based Models for Prediction of Alzheimer's Disease Based on Speech
Balagopalan A., Eyre B., Robin J., Rudzicz F., Novikova J. (2021)
Frontiers in Aging Neuroscience. Read more

Variation in speech and language variables based on demographic factors.
Robin J., Xu M., Simpson W. (2021)
International Society for CNS Clinical Trials and Methodology. Read more

Analytical and clinical validation of digital language assessments.
Robin J., Xu M., Simpson W., Novikova J. (2021)
International Society for CNS Clinical Trials and Methodology. Read more

Augmenting BERT Carefully with Underrepresented Linguistic Features
Balagopalan A., Novikova J. (2020)
Machine Learning for Health Workshop at NeurIPS 2020. Read more

Remote assessment of speech and language changes in Primary Progressive Aphasia (PPA) and behavioral variant Frontotemporal Dementia (bvFTD).
Robin J., Xu M., Kaufman L.D., Hagey M., Paul R., Siddiqui O., Ward M., Simpson W. (2020)
Clinical Trials on Alzheimer’s Disease. Read more

Evaluation of speech-based digital biomarkers for Alzheimer’s Disease.
Robin J., Kaufman L.D., Simpson W. (2020)
Clinical Trials on Alzheimer’s Disease. Read more

Evaluation of Speech-Based Digital Biomarkers: Review and Recommendations.
Robin J., Harrison J.E., Kaufman L.D., Rudzicz F., Simpson W., Yancheva M. (2020)
Digital Biomarkers, 99–108. Read more

Fantastic Features and Where to Find Them: Detecting Cognitive Impairment with a Subsequence Classification Guided Approach
Eyre B., Balagopalan A., Novikova J. (2020)
W-NUT Workshop on Noisy User-generated Text at EMNLP 2020. Read more

Hepatic Encephalopathy is Associated with a Distinct Speech Pattern.
Bloom P.P., Arvind A., Daidone M., Robin J., Xu M., Gupta A.S., Chung R.T. (2020)
American Association for the Study of Liver Diseases: The Liver Meeting. Read more

Gathering normative speech data for depression research remotely, using online task marketplaces.
Fidalgo C., Xu M., Balagopalan A., Robin J., Kaufman L.D., Simpson W. (2020)
International Society for CNS Clinical Trials and Methodology. Read more

A comparison of clinician assessment of speech versus automated speech analysis in Mild Cognitive Impairment and Alzheimer’s Dementia.
Yeung A., Iaboni A., Rochon E., Lavoie M., Santiago C., Yancheva M., Novikova J., Xu M., Robin J., Kaufman L.D., Mostafa F. (2020)
Alzheimer’s Association International Conference. Read more

Quality comparison of remote vs. in-person digital speech assessment for dementia.
Robin J., Novikova J., Sirotkin S., Yancheva M., Kaufman L.D., Simpson W. (2020)
Alzheimer’s Association International Conference. Read more

Comparing longitudinal changes in speech-based digital measures in cognitively healthy, possible cognitive impairment, and MCI/AD individuals.
Robin J., Xu M., Kaufman L.D., Simpson W. (2020)
Alzheimer’s Association International Conference. Read more

To BERT or Not To BERT: Comparing Speech and Language-based Approaches for Alzheimer's Disease Detection
Balagopalan A., Eyre B., Rudzicz F., Novikova J. (2020)
Proceedings of INTERSPEECH 2020. Read more

Assessment of ataxia using natural language processing and computational analysis of speech.
Simpson W., Kaufman L.D., Balagopalan A., Khan N.C., Gupta A.S. (2020)
Ataxia Investigators Meeting. Read more

Tracking changes in cognition in Mild Cognitive Impairment and Alzheimer’s Disease over a 6-month period using a speech-based digital biomarker.
Robin J., Simpson W., Kaufman L.D. (2020)
International Society for CNS Clinical Trials and Methodology. Read more

Pause-Focussed Sequential Modelling for Predicting Cognitive Impairment on Limited Data
Eyre B., Balagopalan A., Novikova J. (2019)
Machine Learning for Health Workshop at NeurIPS 2019. Read more

Evaluating a method for automatic and objective scoring of verbal response for the Montreal Cognitive Assessment (MoCA).
Kaufman L.D., Balagopalan A., Novikova J., Mostafa F. (2019)
Clinical Trials on Alzheimer’s Disease. Read more

Early development of a unified, speech and language composite to assess the clinical severity of Frontotemporal Lobar Degeneration (FTLD).
Balagopalan A., Kaufman L.D., Novikova J., Siddiqui O., Paul R., Ward M., Simpson W. (2019)
Clinical Trials on Alzheimer’s Disease. Read more

Cross-Language Aphasia Detection using Optimal Transport Domain Adaptation
Balagopalan A., Novikova J., McDermott M. B. A., Nestor B., Naumann T., Ghassemi M. (2019)
Machine Learning for Health Workshop at NeurIPS 2019. Read more

Comparing a speech-based digital biomarker to the Montreal Cognitive Assessment (MoCA) for tracking cognition over a 6-month period in a naturalistic cohort of older adults.
Simpson W., Balagopalan A., Kaufman L.D., Yancheva M. (2019)
Clinical Trials on Alzheimer’s Disease. Read more

Lexical Features Are More Vulnerable, Syntactic Features Have More Predictive Power
Novikova J., Balagopalan A., Shkaruta K., Rudzicz F. (2019)
W-NUT Workshop on Noisy User-generated Text at EMNLP 2019. Read more

Use of a voice-based digital biomarker in patients with depression.
Simpson W., Balagopalan A., Kaufman L.D., Yeung A., Butler A (2019)
International Society for CNS Clinical Trials and Methodology. Read more

Utility of speech-based digital biomarkers for evaluating disease progression in clinical trials of Alzheimer’s disease.
Simpson W., Kaufman L.D., Detke M., Lynch S., Butler A., Dominy A. (2019)
Alzheimer’s Association International Conference. Read more

Comparison of a speech-based digital biomarker with the MoCA in a naturalistic cohort of seniors.
Simpson W., Kaufman L.D., Balagopalan A., Novikova J. (2019)
Alzheimer’s Association International Conference. Read more

Using acoustic and linguistic markers from spontaneous speech to predict scores on the Montreal Cognitive Assessment (MoCA).
Balagopalan A., Yancheva M., Novikova J., Simpson W. (2019)
Society of Biological Psychiatry. Read more

Impact of ASR on Alzheimer's Disease Detection: All Errors are Equal, but Deletions are More Equal than Others
Balagopalan A., Shkaruta K., Novikova J. (2019)
W-NUT Workshop on Noisy User-generated Text at EMNLP 2020. Read more

Detecting Cognitive Impairments by Agreeing on Interpretations of Linguistic Features
Zhu Z., Novikova J., Rudzicz F. (2019)
NAACL 2019. Read more

The Effect of Heterogeneous Data for Alzheimer’s Disease Detection from Speech
Balagopalan A., Novikova J., Rudzicz F., Ghassemi M. (2018)
Machine Learning for Health Workshop at NeurIPS 2018. Read more

Semi-supervised Classification by Reaching Consensus Among Modalities
Zhu Z., Novikova J., Rudzicz F. (2018)
IRASL, Interpretability and Robustness in Audio, Speech and Language Workshop at NeurIPS 2018. Read more

Learning Multiview Embeddings for Assessing Dementia
Pou-Prom C., Rudzicz F. (2018)
Proceedings of Empirical Methods in Natural Languages Processing 2018. Read more

A Swedish Cookie-Theft Corpus
Kokkinakis D., Lundholm Fors K., Fraser K.C., Nordlund A. (2018)
Proceedings of the 11th edition of the Language Resources and Evaluation Conference (LREC). Miyazaki, Japan. Read more

On the Importance of Normative Data in Speech-based Assessment
Noorian Z., Pou-Prom C., Rudzicz F. (2017)
Machine Learning for Health Workshop at NIPS 2017. Read more

Rhetorical Structure and Alzheimer’s Disease
Abdalla M., Rudzicz F., Hirst G. (2017)
Aphasiology, 32(1):41-60. Read more

Identifying and Avoiding Confusion in Dialogue with People with Alzheimer’s Disease
Chinaei H., Danks A, Mehta T., Chan-Currie L., Lin H., Rudzicz F. (2017)
Computational Linguistics, 43(2):377-406. Read more

Speech Recognition in Alzheimer’s Disease and in its Assessment
Zhou L., Fraser K., Rudzicz F. (2016)
Proceedings of Interspeech 2016. Read more

Vector-space Topic Models for Detecting Alzheimer's Disease
Yancheva, M., Rudzicz, F. (2016)
Proceedings of the 54th Annual Meeting of the Association for Computational Linguistics (Volume 1: Long Papers). Read more

Toward Dementia Diagnosis via Artificial Intelligence
Rudzicz F. (2016)
Today’s Geriatric Medicine, 9(2):8, March. Read more

Linguistic features identify Alzheimer’s disease in narrative speech
Fraser K., Meltzer J., Rudzicz F. (2015)
Journal of Alzheimer's Disease, 49(2), 407-422. Read more